We hypothesized that the function of duodenocyte apical membrane acid-base transporters are essential for H ϩ absorption from the lumen. We thus examined the effect of inhibition of Na ϩ /H ϩ exchanger-3 (NHE3), cystic fibrosis transmembrane regulator (CFTR), or apical anion exchangers on transmucosal CO 2 diffusion and HCO 3 Ϫ secretion in rat duodenum. Duodena were perfused with a pH 6.4 high CO 2 solution or pH 2.2 low CO2 solution with the NHE3 inhibitor, S3226, the anion transport inhibitor, DIDS, or pretreatment with the potent CFTR inhibitor, CFTRinh-172, with simultaneous measurements of luminal and portal venous (PV) pH and carbon dioxide concentration ([CO2] 
Ϫ secretion helps facilitate CO2/H ϩ absorption. Furthermore, CFTR inhibition prevented CO2-induced cellular acidification reversed by S3226. Reversal of increased HCO 3 Ϫ loss by NHE3 inhibition and reduced intracellular acidification during CFTR inhibition is consistent with activation or unmasking of NHE3 activity by CFTR inhibition, increasing cell surface H ϩ available to neutralize luminal HCO 3 Ϫ with consequent CO2 absorption. NHE3, by secreting H ϩ into the luminal microclimate, facilitates net transmucosal HCO 3 Ϫ absorption with a mechanism similar to proximal tubular HCO 3 Ϫ absorption.
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EPITHELIAL HCO 3
Ϫ SECRETION is considered to be the primary defense against duodenal injury from gastric acid. One of the unexplained mysteries of duodenal HCO 3 Ϫ secretion is why it is needed, given that secretion into the lumen from pancreas and liver is more than adequate to fully neutralize the bulk luminal content (13) . Epithelial HCO 3 Ϫ secretion has thus been hypothesized to neutralize a distinct "preepithelial layer" adjacent to the apical plasma membrane of the mucosa (10, 24) . Moreover, the upper intestine absorbs HCO 3 Ϫ by an electroneutral Na ϩ -dependent mechanism, hypothesized to be Na ϩ /H ϩ exchange (37) . Since the epithelial Na ϩ /H ϩ exchanger (NHE) 3, which helps facilitate intestinal neutral NaCl absorption, is highly expressed in duodenum (31), we wondered whether duodenal NHE3 additionally functions as an H ϩ secretor, as it does in the proximal tubule (33, 38), facilitating HCO 3 Ϫ absorption. The duodenum must also absorb ϳ450 mmol of gastric H ϩ /24 h to decrease luminal hydrogen concentration ([H ϩ ]) by 6 log orders over its 15-cm length (12) . HCl in the duodenal lumen is neutralized by HCO 3 Ϫ secreted by the pancreas and duodenal epithelium. This generates extremely high luminal CO 2 pressures (PCO 2 Ͼ 400 Torr), which are dissipated by the proximal jejunum (32) . Gastric mucosal CO 2 and H ϩ permeability is low, since pyloric obstruction leads to severe metabolic alkalosis due to the inability of the normal stomach to absorb substantial quantities of H ϩ or CO 2 (16) . Thus the duodenum is the major site for intestinal H ϩ and CO 2 absorption.
We have demonstrated sequential transmucosal CO 2 and H ϩ movement from duodenal lumen into the portal vein (PV), facilitated by epithelial cytosolic and membrane-bound carbonic anhydrases (CAs) in the rat (27) . Cellular acidification by luminal CO 2 /H ϩ rapidly induces protective responses such as the hyperemic response, augmented mucus secretion, and HCO 3 Ϫ secretion. Protective mechanisms prevent irreversible cellular acidification (23) .
Our model of transapical CO 2 /H ϩ uptake by the duodenal epithelial cells is based on the Jacobs-Stewart cycle, originally described in 1945 in red cells as a means of transporting large quantities of H ϩ to the lungs via successive CA-facilitated CO 2 7H 2 CO 3 interconversion coupled with transmembrane CO 2 diffusion (22) . Components of the Jacobs-Stewart cycle include cytosolic and membrane-bound CAs in addition to plasma membrane anion exchanger-facilitated HCO 3 Ϫ secretion. In the Jacobs-Stewart cycle, luminal H ϩ , facilitated by membrane-bound CA, neutralizes HCO 3 Ϫ secreted by a plasma membrane anion exchanger, generating CO 2 and H 2 O. CO 2 diffuses through the plasma membrane, where a soluble CA facilitates its hydration into H 2 CO 3 , dissociating to H ϩ and HCO 3 Ϫ . HCO 3 Ϫ is secreted across the plasma membrane by the anion exchanger, completing the cycle. For red cells, cellular H ϩ is transported to the lungs, where the reverse cycle increases plasma CO 2 , which is excreted. For epithelial cells, we demonstrated that HCO 3 Ϫ is secreted across the apical membrane, which, coupled with previously demonstrated H ϩ exit across the basolateral membrane, produces net transepithelial H ϩ absorption (27) . Here, we show that H ϩ can alternatively exit across the apical membrane, facilitating luminal HCO 3 absorption. We have demonstrated that all of the JacobsStewart cycle-associated proteins are well expressed in duodenal epithelial cells (3, 40) and that cytosolic and membranebound CA activities are essential for luminal H ϩ uptake (27) . We now would like to further test the hypothesis that H ϩ , CO 2 , and HCO 3 Ϫ absorption pathways across the apical membrane of duodenal epithelial cells follow the model of the JacobsStewart cycle. We thus examined the contribution of apical acid-base transporters towards duodenal transapical H ϩ , CO 2 , and HCO 3 Ϫ movement. We assumed that the main sources of H ϩ and HCO 3 Ϫ necessary for transmucosal CO 2 movement are the stomach and pancreas, respectively. Yet, in the kidney, CO 2 is generated in the preepithelial microclimate abutting the proximal tubule cell apical membrane by titration of tubular HCO 3 Ϫ with H ϩ secreted by NHE3 or a proton pump (38) . We wondered whether epithelial H ϩ and HCO 3 Ϫ secretion into the preepithelial microclimate were necessary components for transmucosal acid and base movement, as they are in the proximal tubule and have been hypothesized in the proximal intestine (20, 37) . The transport function of NHE3, which plays an important role in lower intestinal Na ϩ absorption, (33) is unclear in the duodenum. We have previously shown that NHE3 is not involved in CO 2 /H ϩ movement between the lumen and cell during high CO 2 exposure (27), nor is it involved in the regulation of enterocyte intracellular pH (pH i ) at neutral luminal pH (15) .
The two major apical transporters that secrete HCO 3 Ϫ into the duodenal lumen are the cystic fibrosis transmembrane conductance regulator (CFTR) and the apical Cl Ϫ /HCO 3 Ϫ anion exchanger in the SLC26A family (9, 40) . CFTR plays a major role in the HCO 3 Ϫ secretion stimulated by the cAMP pathway (9) . Of the SLC26A family, SLC26A3 [downregulated in adenoma (DRA)] and SLC26A6, putative anion transporter 1 (PAT1) are implicated in duodenal HCO 3 Ϫ secretion (21, 39), although their differential axial expression patterns and transport stoichiometries suggest distinct but complementary functions (34) .
The intestine switches between secretion and absorption by reciprocal activation and suppression of the coupled ion exchange proteins NHE3 and SLC26Ax. Secretory proteins such as CFTR are also involved through functional coupling, protein-protein interactions via their postsynaptic density protein-Drosophila disc-large tumor suppressorzonula occludens-1 protein domains, and also through secretion-induced cell shrinkage (17) . In the duodenum, where SLC26A is implicated in HCO 3 Ϫ secretion rather than in Cl Ϫ absorption, this mechanism is less clear. We have shown that the selective NHE3 inhibitor, S3226, increases duodenal HCO 3 Ϫ secretion via CFTR activation rather than by decreasing the neutralization of HCO 3 Ϫ by NHE3-secreted H ϩ (15) . To further study the role of NHE3 in luminal acid absorption, we hypothesized that NHE3 acidifies the enterocyte preepithelial microclimate, neutralizing SLC26Ax-secreted HCO 3 Ϫ to CO 2 and H 2 O and facilitating CO 2 absorption across the apical membrane and through the mucosa. We further hypothesized that CFTR inhibition would reciprocally activate NHE3 activity, "unmasking" its role in duodenal HCO 3 Ϫ absorption. (26) . It was purified with high-performance liquid chromatography with the structure verified by nuclear magnetic resonance (4). S3226, a selective NHE3 inhibitor (15) was a kind gift of Aventis Pharma Deutschland (Frankfurt am Main, Germany). BCECF acid and its acetoxy methyl ester (BCECF-AM) and DIDS were obtained from Molecular Probes (Eugene, OR). NaHCO3, HEPES, and all other chemicals were obtained from Sigma Chemical (St. Louis, MO). Krebs solution contained (in mM) 136 NaCl, 2.6 KCl, 1.8 CaCl2, and 10 HEPES at pH 7.0. For neutral pH/high CO 2 perfusion, solutions were made as previously described (3, 14, 27 ) using a 50 mM NaHCO 3-105 mM NaCl solution and 20 mM HCl-135 mM NaCl solution, generating an isotonic (310 mosM) pH 6.4 solution with PCO 2 ϭ 260 Torr, calculated using a CO2 aqueous solubility constant of 0.0321 mM/Torr and the first negative log of acidic dissociation constant (pKa) of carbonic acid ϭ 6.1 at 37°C. Solutions were vigorously mixed 1 min before perfusion. We confirmed that the pH of the freshly mixed solution reached steady-state within 10 s, whereas carbon dioxide concentration ([CO2]) reached its equilibrium of carbonic acid, H ϩ , and HCO 3 Ϫ by 1 min and was stable for at least 10 min, as measured by pH and CO 2 electrodes (Lazar Research Laboratories, Los Angeles, CA). Each solution was prewarmed at 37°C with the use of a water bath, and the temperature was maintained with a heating pad during the experiment. For low pH/low CO2 perfusion, pH 2.2 saline was used. CFTRinh-172 was dissolved with DMSO at 1 mg/10 l for intraperitoneal injection. The stock solution was kept in Ϫ20°C until use. DMSO (1%) in saline was used as vehicle for intraperitoneal injection. S3226 was dissolved in DMSO, and DIDS was in distilled water and then stored at Ϫ20°C until use. DMSO (0.1%) in saline was used for vehicle perfusions. All studies were performed with approval of the Veterans Affairs Institutional Animal Care and Use Committee (VA IACUC). Male SpragueDawley rats weighing 200 -250 g (Harlan, San Diego, CA) were fasted overnight but had free access to water.
MATERIALS AND METHODS

Chemicals
Measurement of luminal pH and [CO2].
According to a previously reported method (27) , a duodenal loop was prepared and perfused, and pH and [CO 2] in the perfusate and effluent were simultaneously and continuously measured with flow-through pH and CO 2 electrodes. In brief, under isoflurane anesthesia (1.5-2.0%) with the use of a rodent anesthesia inhalation system (Summit Medical Systems, Bend, OR), rats were placed supine on a water recirculating heating block system (Summit Medical) to maintain body temperature at 36 -37°C, as monitored by a rectal thermistor. Prewarmed saline was infused via the right femoral vein at 1.08 ml/h using a Harvard infusion pump (Harvard Apparatus, Holliston, MA). Using a pressure transducer (Kent Scientific, Torrington, CT), blood pressure was monitored via a catheter placed in the left femoral artery. The abdomen was incised, both stomach and duodenum were exposed, and the forestomach wall was incised 0.5 cm using a thermal cautery (Geiger Medical Technologies, Monarch Beach, CA). A polyethylene tube (diameter 5 mm) was inserted through the incision until it was 0.5 cm caudal from the pyloric ring, where it was secured with a nylon ligature. The distal duodenum was ligated proximal to the ligament of Treitz before the duodenal loop was filled with 1 ml saline prewarmed at 37°C. The distal duodenum was then incised, and another polyethylene tube was inserted through the incision and sutured into place. To prevent contamination of the perfusate from bile or pancreatic juice, the pancreaticobiliary duct was ligated just proximal to its insertion into the duodenal wall and cannulated with a polyethylene (PE-10) tube to drain the juice. The resultant closed proximal duodenal loop (perfused length 2 cm) was perfused with prewarmed saline by using a peristaltic pump (Fisher Scientific, Pittsburgh, PA) at 1 ml/min. Input (perfusate) and effluent pH and [CO2] were continuously measured with two sets of pH and CO2 electrodes, respectively, placed in series using flow-through cells (Micro Flow-Through pH and CO2 electrodes, Lazar Research Laboratories). These flow-through cells were immersed in a water bath maintained at 37°C by a thermo regulator (Fisher Scientific). CO 2 electrodes were calibrated every day with 0.1, 1.0, and 10 mM NaHCO3 in pH 4 citrate buffer, which generated 0.1, 1.0, and 10 mM total CO2 content ([total CO2]), respectively. This system enabled us to calculate the changes in the concentration of luminal CO 2, total CO2, HCO 3 Ϫ , and H ϩ by the following equations derived from the Henderson-Hasselbalch equation
where [CO2] (mM) was calculated according to the calibration curve as mentioned above, [HCO 3 Ϫ ] is the bicarbonate concentration, and pKa, the first dissociation constant of carbonic acid, ϭ 6.1 at 37°C. Note that [CO2] directly measured by a CO2 electrode is described as a concentration (mM), distinct from PCO2 (Torr), which is calculated from Henry's law and the measured [CO2] as mentioned above
where Kh, the Henry solubility constant for subsaturating CO2 concentrations in weak electrolyte solutions, is 0.0321 mM/Torr at 37°C. The net changes in concentration were determined as
expressed so that positive quantities denote net secretion whereas negative quantities indicate net absorption from the lumen. For example Ϫ secretion into the neutral pH perfusate, we calculated [total CO2] (mM) in the neutral pH solution from Eq. 1. For saline ([CO2] ϳ 0) perfusion, the perfusate and effluent were circulated through a reservoir in which the perfusate was bubbled with 100% O2 and stirred and warmed at 37°C with a heating stirrer (Barnstead Int., Dubuque, IO). The pH of the perfusate was kept constant at pH 7.0 with a pH stat (model nos. PHM290 and ABU901; Radiometer Analytical, Lyon, France). For high CO 2 or acid solution perfusion, the perfusate was infused with a Harvard syringe pump, and the effluent was discarded. We have reported that pH and [CO 2] in the input perfusate are almost constant during a high CO2 perfusion for 10 min (27) .
Measurement of portal venous pH and PCO2. Portal blood samples were obtained from the gastroduodenal branch of the PV at the end of the challenge period as previously described (27) , and pH and PCO2 were measured with a blood gas analyzer (ABL5; Radiometer, Copenhagen, Denmark).
Experimental protocol. After stabilizing the pH and [CO 2] measurements with continuous perfusion of pH 7.0 saline for ϳ30 min, the time was defined as t ϭ 0. The duodenal loop was perfused with pH 7.0 saline from t ϭ 0 min until t ϭ 20 min (basal period). The perfusate was then changed to either a pH 6.4 saline ([CO 2] ϳ 0, [HCO 3 Ϫ ] ϭ 0, neutral pH/low CO2 solution), a high CO2 solution (pH 6.4, PCO2 260 Torr, neutral pH/high CO2 solution) prepared as described above, or a pH 2.2 acid saline ([CO 2] ϳ 0, [HCO 3 Ϫ ] ϳ 0, low pH/low CO2 solution), from t ϭ 20 min until t ϭ 30 min (challenge period), with or without inclusion of inhibitors as described below. At t ϭ 20 min, the system was gently flushed manually to rapidly change the composition of the perfusate. During the challenge period, the solution was perfused with a syringe pump. At the end of the challenge period (t ϭ 30 min, 10 min after CO 2 or acid stress), an aliquot of portal blood was analyzed. Abdominal aortic blood was analyzed as a comparator.
To examine the effect of the inhibition of CFTR on luminal and PV pH and [CO 2], the animals were pretreated with CFTRinh-172 (1 mg/kg ip) or vehicle 1 h before anesthesia commenced. This pretreatment is confirmed to inhibit acid-induced HCO 3 Ϫ secretion due to CFTR inhibition in rat duodenum (4) . Furthermore, CFTRinh-172 has been recognized as a potent and selective CFTR inhibitor in the gastrointestinal tract of rodents (26, 36) , although its efficacy is dependent on tissue type (less potent in airway epithelia) and species (less potent in pig and ferret than in human and mouse) (25) . CFTR inh-172 inhibition can mimic CFTR dysfunction in human tracheal epithelia (29) . To examine the effect of the inhibition of NHE3 or anion exchanger/Na ϩ :HCO 3 Ϫ cotransporter (NBC), S3226 (10 M) (15, 27) or DIDS (0.1 mM) (14) , respectively, were perfused with the high CO 2 solution or acid solution. We confirmed that S3226 or DIDS in these concentrations had no effect on solution pH or [CO 2]. Neither inhibitors nor high CO2 or acid perfusate had any measurable change on body temperature, blood pressure, or arterial blood gas analysis.
pH i and blood flow measurement. To further examine the effect of CFTR or NHE3 inhibition during CO2 exposure on the epithelial function in rat duodenum, the pHi of the upper villous epithelial cells and blood flow were simultaneously measured using BCECF fluorescence ratio imaging and laser Doppler flowmetry as described elsewhere (3, 5) . Under isoflurane anesthesia, BCECF-loaded, chambered duodenal mucosa was superfused with pH 7.0 Krebs buffer solution for 10 min (basal period), followed with pH 6.4 saline (PCO 2 ϳ 0 Torr) or pH 6.4 high CO2 solution (PCO2 ϭ 260 Torr) with or without S3226 (10 M) for 10 min (challenge period), then with pH 7.0 Krebs for 15 min (recovery period). Rats were pretreated with vehicle or CFTR inh-172 (1 mg/kg ip) 1 h before the experiment started.
Statistics. All data was derived from experimental groups with n ϭ 6 and were expressed as means Ϯ SE. Comparisons between groups were made by one-way ANOVA followed by Fischer's least significant difference test. P Ͻ 0.05 was taken as significant. Ϫ ], respectively) during the basal period (t ϭ 0 -20 min), as previously reported (27) . The time point t ϭ 30 min, 10 min after changing the solution to the challenge or test solution, was chosen to allow for equilibration of the perfusate with the mucosa and also to coincide with portal blood measurements as previously described (27) . Ϫ ] was increased during exposure to high CO 2 . This is consistent with the simultaneous net movement of CO 2 from perfusate to mucosa (absorption) and HCO 3 Ϫ output into the lumen (secretion) (Fig. 1, A and B) or luminal conversion of CO 2 to HCO 3 Ϫ in bulk solution. Furthermore, perfusion of the high CO 2 solution lowered PV pH and elevated PV PCO 2 (Fig.  1, C and D) , consistent with CO 2 or H ϩ absorption into the PV blood. This demonstrates CO 2 movement from lumen to mucosa, rather than luminal conversion of CO 2 to HCO 3 Ϫ . To test the hypothesis that CFTR inhibition augments NHE3 activity, we first examined the effect of CFTR inhibition on CO 2 /HCO 3 Ϫ movement during high CO 2 exposure. CFTR inh -172 pretreatment (1 mg/kg ip, 1 h before) had no effect on the basal ⌬[CO 2 ] and ⌬[HCO 3 Ϫ ], with no change of PV pH and PCO 2 . This is consistent with the previous data that CFTR inh -172 has no effect on the basal HCO 3 Ϫ secretion but inhibits acid-induced HCO 3 Ϫ secretion in rat duodenum (4). In contrast, CFTR inh -172 converted luminal CO 2 -induced HCO 3 Ϫ secretion to HCO 3 Ϫ loss (Fig. 1, A and B) , reversing the transport of luminal CO 2 to the PV (Fig. 1, C and D) . These results suggest that CFTR inhibition either activates apical Na ϩ /H ϩ exchange, decreasing luminal [HCO 3 Ϫ ] during high CO 2 exposure (the high CO 2 solution contains 8 mM CO 2 and 16 mM HCO 3 Ϫ ), or activates apical anion exchangers to absorb rather than secrete HCO 3 Ϫ . To test these possibilities, we examined the effect of NHE3 inhibition during high CO 2 exposure. Although a selective NHE3 inhibitor, S3226 (10 M), itself has no effect on CO 2 /H ϩ movement (27) , S3226 perfusion during high CO 2 exposure reversed CFTR inh -172-induced HCO 3 Ϫ absorption and CO 2 loss (Fig. 1. A and B) . This suggests that NHE3 is activated by CFTR inhibition during high CO 2 exposure, secreting H ϩ into the lumen to neutralize HCO 3 Ϫ . We then examined the contribution of apical anion exchangers to net CO 2 and HCO 3 Ϫ movement. Luminal DIDS (0.1 mM), the stilbene anion transport inhibitor, had no additive effect on CFTR inh -172-induced HCO 3 Ϫ loss and PV changes during CO 2 exposure (Figs. 2, A-D) , suggesting that a DIDSsensitive anion exchanger is not involved in the effect of CFTR inhibition. Furthermore, DIDS and CFTR inh -172 had similar effects during CO 2 exposure. DIDS did not alter CO 2 absorption, but rather increased HCO 3 Ϫ loss and inhibited PV acidification and PCO 2 increase (Fig. 3, A-D) . Nevertheless, these DIDS-related effects were not affected by S3226 (10 M), suggesting that its effects on CO 2 /HCO 3 Ϫ movement occurred by a different mechanism than by CFTR inhibition. The differential expression pattern of SLC26A3 (DRA) and SLC26A6 (PAT1) along the intestinal longitudinal axis (duodenum to colon) and crypt-villous axis (35, 39) and their differential sensitivity to DIDS (SLC26A3 is DIDS insensitive, whereas SLC26A6 is DIDS sensitive) (7, 30) suggest that DIDS may preferentially inhibit duodenal SLC26A6. Since luminal DIDS Ն 0.5 mM likely inhibits the basolateral NBC as previously reported (2), we also examined the effect of DIDS (0.5 mM) on CO 2 /HCO 3 Ϫ movement. Since the effect of 0.5 mM DIDS was the same as the effect of 0.1 mM DIDS (data not shown), DIDS presumably inhibits the apical SLC26A (presumably A6) anion exchanger and the basolateral NBC at the concentration used.
RESULTS
Luminal high CO
Taken together, during high CO 2 exposure, CFTR and apical anion exchangers are involved in HCO 3 Ϫ secretion and PV acidification, but NHE3 is not. (Fig. 4, A and B) . This is similar to our previous reports (1, 27) and consistent with partial CO 2 loss or diminution of HCO 3 Ϫ secretion and H ϩ loss during acid perfusion. Note that, in most publications in which duodenal HCO 3 Ϫ secretion is measured, HCO 3 Ϫ secretion is increased at least 10 min after the termination of acid perfusion, where it is measured as titratable alkalinity of a HCO 3 Ϫ -free perfusate, unlike what we report here (see Ref. 1). Perfusion with pH 2.2 saline was accompanied by PV acidification and PCO 2 increase (Fig. 4, C and  D) , corresponding to transmucosal CO 2 or H ϩ absorption. CFTR inh -172 had no effect on HCO 3 Ϫ or CO 2 movement during the basal period, again showing that CFTR inh -172 has no effect on basal HCO 3 Ϫ secretion. Nonetheless, CFTR inh -172 diminished the decrease of total CO 2 output and the increase of H ϩ loss during acid perfusion (Fig. 4, A and B) and diminished PV acidification (Fig. 4, C and D) , suggesting that CFTR is positively involved in the transmucosal movement of CO 2 /H ϩ during acid exposure. Despite having no significant effect on total CO 2 output (Fig. 5A) , DIDS reduced H ϩ loss (Fig. 5B ) and inhibited PV acidification during acid exposure (Fig. 5, C and D) . In contrast, S3226, which had no effect on the acid-induced H ϩ loss or PV acidification (Fig.  5, B-D) , increased total CO 2 output, similar to the previously observed augmented HCO 3 Ϫ secretion during NHE inhibition (15) . These results suggest that, during luminal acid perfusion, HCO 3 Ϫ secretion and transmucosal CO 2 and H ϩ movement are mediated by CFTR and DIDS-sensitive transporters but not by NHE3. 
Effect of CFTR inhibition on epithelial cell pH i during
luminal CO 2 exposure. Since CO 2 acidifies cells, we next measured pH i under the same conditions to measure CO 2 movement into the enterocytes. During CO 2 challenge, epithelial cell pH i fell, followed by recovery and overshoot (reaching over the baseline) after CO 2 removal (Fig. 6A) and was accompanied by a hyperemic response (Fig. 6B) as previously described (3) . Coperfusion of S3226 with the high CO 2 solution had no effect on CO 2 -induced intracellular acidification and CO 2 -induced hyperemia (Fig. 6, A and B) , consistent with a prior report (27) . CFTR inh -172 pretreatment reduced CO 2 -induced acidification during the challenge period and eliminated the overshoot during the recovery period (Fig. 7A) , confirming our early observations that CFTR dysfunction reduces acid-induced cellular acidification (18) . Furthermore, CFTR inh -172 prevented CO 2 -induced hyperemia (Fig. 7B) , probably due to the inhibition of intracellular acidification, which is necessary to trigger a hyperemic response (3). With CFTR inhibition, S3226 reversed the effect of CFTR inh -172 during the CO 2 challenge period, followed by a delayed pH i recovery (Fig. 7A ) and a delayed hyperemic response to CO 2 perfusion (Fig. 7B) . CFTR inhibition during CO 2 challenge might thus activate apical NHE3 to secrete H ϩ , consistent with the reciprocal activation of NHE3 during CFTR inhibition. The small magnitude of cellular acidification in this instance appeared insufficient to induce a hyperemic response. Simultaneous inhibition of CFTR and NHE3 during CO 2 challenge enabled CO 2 diffusion into the cells, which acidified cells similarly to the CO 2 alone group. This observation, compared with the observed lack of CO 2 loss and PV acidification in this condition (shown in Fig. 1 ), suggests that simultaneous CFTR and NHE3 inhibition affected basolateral acid-base transporters, as was previously suggested (28) .
DISCUSSION
We demonstrated that CFTR inhibition induced NHE3-dependent HCO 3 Ϫ absorption from the lumen during CO 2 challenge but inhibited CO 2 /H ϩ absorption and PV acidification during acid challenge. Furthermore, DIDS augmented HCO 3 Ϫ absorption during CO 2 exposure independent of NHE3 activation, and inhibited CO 2 /H ϩ absorption and PV acidification during acid exposure. NHE3 inhibition alone had no effect on transmucosal CO 2 /H ϩ movement during acid or CO 2 exposure, as previously demonstrated (27) . This is the first study indicating that CFTR inhibition activates NHE3-related transport activity during CO 2 exposure in vivo in rat duodenum. Since NHE3 inhibition activates CFTR in vivo (15), our results are consistent with the reciprocal activation of CFTR and NHE3 in rat duodenum. Moreover, since CFTR inhibition and DIDS both inhibit stimulated duodenal HCO 3 Ϫ secretion (2, 4), our study suggests that HCO 3 Ϫ secretion is essential for the absorption of CO 2 /H ϩ from the duodenal lumen into the PV. To explain the movement of CO 2 into and out of the duodenal mucosa, we have postulated a model (Fig. 8) in which the erythrocyte-based Jacobs-Stewart cycle (22) is present across the apical brush-border membrane of duodenal epithelial cells (3, 27 Ϫ is transported to the subepithelium, where it is taken up by the basolateral NBC into the enterocyte cytoplasm, its amount dependent on blood flow. After uptake, intracellular HCO 3 Ϫ exits via apical ion transporters such as CFTR and SLC26A family (Fig. 8A) . Membrane-bound apical CA facilitates the interconversion of luminal CO 2 and HCO 3 Ϫ . The Jacobs-Stewart cycle-based model predicts that the inhibition of epithelial HCO 3 Ϫ secretion inhibits CO 2 diffusion from lumen to PV by depleting the microclimate of titratable HCO 3 Ϫ . CFTR inhibition reversed HCO 3 Ϫ secretion to net HCO 3 Ϫ absorption during exposure to luminal high CO 2 , with impairment of PV acidification. This HCO 3 Ϫ absorption during CFTR inhibition can be attributed to the activity of an apical anion exchanger, presumably SLC26A6, which might absorb HCO 3 Ϫ due to its 2 HCO 3 Ϫ :1 Cl Ϫ stoichiometry under favorable gradients. The other major possibility is that H ϩ secreted by NHE3 is neutralized by luminal HCO 3 Ϫ to CO 2 , which then diffuses into the cells, measured as net HCO 3 Ϫ absorption. In both cases, there is no actual transmucosal H ϩ movement and thus no measurable PV acidification. Since NHE3 inhibitor reversed, but DIDS had no effect on CFTR inhibition-related enhanced HCO 3 Ϫ absorption, the most likely of these possibilities is that HCO 3 Ϫ is absorbed across the apical membrane by titration to CO 2 by H ϩ secreted by NHE3 (Fig. 8B) . In the absence of CFTR inhibition, DIDS increased HCO 3 Ϫ absorption, which was unaffected by NHE3 inhibition, suggesting that inhibition of HCO 3 Ϫ secretion itself is not sufficient to activate NHE3. Another possibility is that DIDS inhibits basolateral NBC activity, lowering intracellular [HCO 3 Ϫ ], increasing the gradient for HCO 3 Ϫ uptake from lumen to cell (2). Furthermore, although S3226 increased HCO 3 Ϫ secretion via CFTR activation (15) , S3226 has no effect on CO 2 /HCO 3 Ϫ movement during CO 2 exposure (27) , suggesting that the presence of luminal HCO 3 Ϫ or CO 2 may mask S3226-induced HCO 3 Ϫ secretion. Therefore, DIDS most likely impairs basolateral HCO 3 Ϫ uptake due to NBC inhibition, diminishing the effect of S3226-induced CFTR activation on HCO 3 Ϫ secretion. During acid challenge, impairment of HCO 3 Ϫ secretion by CFTR inhibition or by DIDS reduced H ϩ loss from the lumen and reduced transmucosal H ϩ absorption, supporting our hypothesis that HCO 3 Ϫ secretion is essential for net H ϩ absorption through the duodenal mucosa. This also confirms the presence of a transapical Jacobs-Stewart cycle (Fig. 8, C and D) .
Another means of demonstrating a CFTR-NHE3 interaction is to examine the effect of CFTR or NHE3 inhibition on epithelial cell pH i . In the pH i study, CO 2 -induced intracellular acidification was reduced by CFTR inh -172 pretreatment and was increased by NHE3 inhibition, suggesting that CFTR inhibition activated NHE3 function, supporting our hypothesis. Nevertheless, CO 2 -induced intracellular acidification was not associated with PV acidification or with PV CO 2 increase when CFTR and NHE3 were inhibited simultaneously. Furthermore, delayed recovery of pH i and a delayed hyperemic response to luminal CO 2 during dual inhibition of CFTR and NHE3 sug- A: luminal CO2 diffuses into and acidifies epithelial cells due to cytosolic carbonic anhydrase (CA) activity. The generated H ϩ exits via basolateral NHE1 into the subepithelium, acidifying the PV blood. HCO 3 Ϫ , generated by cellular CA and entering via the basolateral NBC, exits via CFTR/SLC26A into the preepithelial layer, creating an alkaline microclimate, followed by conversion to CO2 by extracellular CA. Generated CO2 rediffuses into the mucosa, completing the Jacob-Stewart cycle across the apical membrane. Finally, effluent pH increases due to the presence of secreted HCO 3 Ϫ and absorbed CO2. In this condition, apical NHE3 is inactive or its activity is masked (see Ref. 27 gest that disruption of apical ion transporters affects the function of basolateral acid-base transporters such as NHE1. NHE1 is the major pH i regulator, implicated in the mechanism of acid and CO 2 -induced hyperemia (3, 5) and in CO 2 /H ϩ movement from the lumen to PV (27) . Luminal CO 2 similarly acidified the cells during inhibition of CFTR and NHE3 but did not increase blood flow, despite intracellular acidification, also suggesting disruption of basolateral H ϩ extrusion or submucosal chemosensing.
When luminal pH is neutral, NHE3 inhibition activates CFTR to secrete HCO 3 Ϫ , whereas, during CO 2 challenge, CFTR inhibition activates NHE3 to secrete H ϩ , facilitating CO 2 absorption. These findings indicate reciprocal activation of NHE3 and CFTR. CFTR and NHE3 interact via a shared regulatory complex consisting of NHE regulatory factors, ezrin, and PKA (11, 41) . It is unclear, however, whether CFTR and NHE3 are coexpressed in the same cells. CFTR is expressed much less than NHE3 since CFTR is located predominantly in the crypts and basal parts of the villi (6), whereas NHE3 is most strongly expressed in the villous cells (19) .
Traditionally, the duodenum is considered to be a net HCO 3 Ϫ secretor, although most prior measurements were made using HCO 3 Ϫ -free perfusates. This created an exaggerated serosal-tolumen HCO 3 Ϫ gradient, rather than the reduced outward gradient formed when physiological [HCO 3 Ϫ ] (ϳ16 mM) and [CO 2 ] (ϳ8 mM) are present in the perfusate (20, 32, 37) . In the presence of a more physiological plasma-to-lumen HCO 3 Ϫ gradient, we demonstrated that net HCO 3 Ϫ absorption can occur. This absorption is facilitated by NHE3-mediated H ϩ secretion only when CFTR is inhibited, again indicating that CFTR inhibition upregulates NHE3 activity. The HCO 3 Ϫ absorptive mechanism of the renal proximal tubule is also dependent on NHE3-dependent H ϩ secretion (8) . We speculate that this reciprocal functional activation of CFTR and NHE3 regulates microclimate pH of the duodenal epithelium and may explain defective cellular acidification associated with CFTR dysfunction (2, 18) .
We previously hypothesized that defective cellular acidification associated with CFTR dysfunction explains the observed scarcity of duodenal ulceration in CF patients, despite the presence of impaired pancreatic and duodenal HCO 3 Ϫ secretion (18) . We had previously speculated that the impaired apical HCO 3 Ϫ secretion, coupled with intact basolateral HCO 3 Ϫ uptake, traps HCO 3 Ϫ in the cytosol and raises pH i . Augmented NHE3 function could prevent further acidification in the presence of a luminal acid load.
In conclusion, CFTR and NHE3 are reciprocally regulated; CFTR inhibition unmasks NHE3 activity particularly during luminal CO 2 rather than during H ϩ stress. Epithelial HCO 3 Ϫ secretion is essential for transapical epithelial CO 2 and H ϩ absorption in rat duodenal mucosa by the JacobsStewart cycle.
